11-142
Showing 1 - 25 of 7,310
Atopic Dermatitis Trial in Germany, Poland (Lebrikizumab)
Recruiting
- Atopic Dermatitis
- Lebrikizumab
-
Darmstadt, Hessen, Germany
- +31 more
Jun 21, 2023
Patients With Mild or Moderate Hepatic Impairment Trial in Tokyo (TS-142 5 mg)
Recruiting
- Patients With Mild or Moderate Hepatic Impairment
- TS-142 5 mg
-
Tokyo, JapanTaisho Pharmaceutical Co., Ltd selected site
Dec 27, 2022
Healthy Male Subjects Trial in Tokyo ([14C] TS-142)
Completed
- Healthy Male Subjects
- [14C] TS-142
-
Tokyo, JapanTaisho Pharmaceutical Co., Ltd selected site
Oct 5, 2022
Urinary Exosome in Type 2 Diabetic Nephropathy and Evaluation of
Active, not recruiting
- Diabetic Nephropathy
- Grouping based on previous laboratory results, no intervention.
-
Jinan, Shandong, ChinaQianfoshan Hospital
Oct 24, 2023
Dental Caries Trial in Talca (Self-etching Adhesive, Glass Ionomer)
Completed
- Dental Caries
- Self-etching Adhesive
- Glass Ionomer
-
Talca, No State, ChileFaculty of Health Sciences
Dec 26, 2022
Dentin Sensitivity Trial in Peshawar (Self etch dentin adhesive, Fluoride varnish)
Not yet recruiting
- Dentin Sensitivity
- Self etch dentin adhesive, Fluoride varnish
-
Peshawar, Khyber Pakhtunkhwa, PakistanPeshawar Dental College
Jun 7, 2023
Noise-induced Hearing Loss Trial in Fort Jackson (D-methionine, Placebo)
Terminated
- Noise-induced Hearing Loss
- D-methionine
- Placebo
-
Fort Jackson, South CarolinaMoncrief Army Community Hospital
Jun 2, 2022
Traveler's Diarrhea Trial (Rifamycin SV-MMX, Placebo)
Not yet recruiting
- Traveler's Diarrhea
- Rifamycin SV-MMX
- Placebo
- (no location specified)
Jan 26, 2023
Effect of Food Trial in Tokyo (TS-142 10 mg)
Not yet recruiting
- Effect of Food
- TS-142 10 mg
-
Tokyo, JapanTaisho Pharmaceutical Co., Ltd selected site
Jan 22, 2023
Eczema, Atopic Dermatitis Trial in Worldwide (KY1005, Placebo)
Active, not recruiting
- Eczema
- Atopic Dermatitis
- KY1005
- Placebo
-
Fremont, California
- +102 more
Dec 13, 2022
The Next-day Residual Effects Trial in Tokyo (TS-142, Zopiclone, Placebo)
Not yet recruiting
- The Next-day Residual Effects
- TS-142
- +2 more
-
Tokyo, JapanTaisho Pharmaceutical Co., Ltd selected site
Apr 6, 2023
Healthy Subjects Trial in Toshima-ku (TS-142, Moxifloxacin, Placebo)
Completed
- Healthy Subjects
- TS-142
- +2 more
-
Toshima-ku, JapanTaisho Pharmaceutical Co., Ltd selected site
Oct 5, 2022
GERD, Hiatal Hernia Trial in United States (LAPAROSCOPIC PARAESOPHAGEAL HIATAL HERNIA REPAIR COMBINED WITH TRANSORAL
Recruiting
- GERD
- Hiatal Hernia
- LAPAROSCOPIC PARAESOPHAGEAL HIATAL HERNIA REPAIR COMBINED WITH TRANSORAL INCISIONLESS FUNDOPLICATION
-
Irvine, California
- +6 more
Jan 31, 2023
Healthy Volunteer Trial in Sumida-ku (Step 1: TS-142, Step 2: TS-142, Step 2: Placebo)
Completed
- Healthy Volunteer
- Step 1: TS-142
- +2 more
-
Sumida-ku, Tokyo, JapanSumida Hospital
Oct 4, 2022
Healthy Subjects Trial in Tokyo (TS-142, Itraconazole)
Completed
- Healthy Subjects
-
Tokyo, JapanTaisho Pharmaceutical Co., Ltd selected site
Oct 4, 2022
Weight Gain, Weight Loss Trial in San Antonio (Gestational weight gain intervention, Postpartum weight loss intervention)
Completed
- Weight Gain
- Weight Loss
- Gestational weight gain intervention
- Postpartum weight loss intervention
-
San Antonio, Texas
- +1 more
Dec 2, 2022
Meniere's Disease Trial in San Diego (OTO-104)
Terminated
- Meniere's Disease
-
San Diego, CaliforniaMany sites in Europe. Refer to the contact info listed below.
Dec 28, 2022
Facial Papulopustular Rosacea Trial in United States (FMX103 minocycline foam 1.5%, Vehicle foam)
Completed
- Facial Papulopustular Rosacea
- FMX103 minocycline foam 1.5%
- Vehicle foam
-
Tucson, Arizona
- +53 more
Jan 27, 2021
Systemic Lupus Erythematosus (SLE) Trial in Worldwide (BIIB059, BIIB059-matching )
Recruiting
- Systemic Lupus Erythematosus (SLE)
- BIIB059
- BIIB059-matching placebo
-
Mesa, Arizona
- +280 more
Jul 20, 2022
Autism Spectrum Disorder, Parenting, Parenting Intervention Trial in Columbus (Attend Behavior Parent Training)
Recruiting
- Autism Spectrum Disorder
- +2 more
- Attend Behavior Parent Training
-
Columbus, OhioOhio State University College of Nursing
Jan 20, 2023
Temporomandibular Joint in Patients With Rheumatoid Arthritis
Completed
- Temporomandibular Joint Disorders
- Rheumatoid Arthritis
- seropositivity of rheumatoid factor
-
Damascus, Syrian Arab RepublicFaculty of Medicine, Damascus University, Syria
Nov 17, 2023